The treatment of hyperlipidemia in patients infected with HIV is discussed. Hyperlipidemia is common in HIV-infected patients receiving antiretroviral therapy, especially protease inhibitors and ...
NCEP guidelines recommend monitoring LDL cholesterol levels four to six weeks after the start of lipid-lowering therapy and then at three months. [9] Although the optimum follow-up times for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback